share_log

Molina Healthcare's (NYSE:MOH) Five-year Total Shareholder Returns Outpace the Underlying Earnings Growth

Molina Healthcare's (NYSE:MOH) Five-year Total Shareholder Returns Outpace the Underlying Earnings Growth

Molina Healthcare(molina healthcare)的股東總收益在五年內超過了潛在的盈利增長。
Simply Wall St ·  07/16 11:50

While Molina Healthcare, Inc. (NYSE:MOH) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 21% in the last quarter. But in stark contrast, the returns over the last half decade have impressed. It's fair to say most would be happy with 101% the gain in that time. So while it's never fun to see a share price fall, it's important to look at a longer time horizon. Only time will tell if there is still too much optimism currently reflected in the share price.

儘管Molina Healthcare, Inc. (紐交所:MOH)的股東可能普遍感到滿意,但股票最近運行不佳,上季度股票價格下跌了21%。但與此形成鮮明對比的是,在過去的五年中,其回報表現引人注目。可以公正地說,多數人對於在這段時間內獲得101%的收益率感到滿意。因此,雖然看到股票價格下跌從來不是一件愉快的事情,但重要的是要把時間範圍拉得更長。只有時間才能告訴我們目前的股票價格是否仍然存在過度樂觀的情況。

Since the long term performance has been good but there's been a recent pullback of 3.0%, let's check if the fundamentals match the share price.

由於長期表現良好,但最近出現了3.0%的回撤,因此讓我們檢查基本面是否與股價相匹配。

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

雖然市場是一個強大的定價機制,但股價反映的不僅僅是企業的基本業績,還有投資者的情緒。一個不完美但簡單的方式來考慮公司市場意識的變化是比較每股收益(EPS)的變化和股價的變化。

During five years of share price growth, Molina Healthcare achieved compound earnings per share (EPS) growth of 7.2% per year. This EPS growth is lower than the 15% average annual increase in the share price. This suggests that market participants hold the company in higher regard, these days. That's not necessarily surprising considering the five-year track record of earnings growth.

在五年的股價增長期間,Molina Healthcare每股收益複合增長率爲7.2%。這一收益率低於股價每年平均增長15%。這表明市場參與者現在更高地看好該公司。考慮到五年的盈利增長記錄,這並不令人意外。

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

該公司的每股收益(隨時間的推移)如下圖所示(單擊可查看確切數字)。

big
NYSE:MOH Earnings Per Share Growth July 16th 2024
紐交所:MOH每股收益增長截至2024年7月16日。

We know that Molina Healthcare has improved its bottom line lately, but is it going to grow revenue? You could check out this free report showing analyst revenue forecasts.

我們知道Molina Healthcare最近已經改善了其底線,但它是否會增加營業收入?您可以查看此免費報告,了解分析師對於營收的預測。

A Different Perspective

不同的觀點

While the broader market gained around 24% in the last year, Molina Healthcare shareholders lost 5.3%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Longer term investors wouldn't be so upset, since they would have made 15%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. Before spending more time on Molina Healthcare it might be wise to click here to see if insiders have been buying or selling shares.

儘管更廣泛的市場在過去一年中增長約24%,但Molina Healthcare的股東卻損失了5.3%。然而,需要記住的是,即使是最好的股票有時也會在十二個月的時間內表現不佳。長期投資者不會太沮喪,因爲在過去的五年中,他們每年都獲得了15%的收益率。如果基本數據繼續表明具有長期可持續增長性,當前的拋售可能值得考慮。在進一步研究Molina Healthcare之前,最好點擊此處查看內部人員是否一直在買賣股票。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

當然,您可能在其他地方找到一家出色的企業進行投資。因此,請查看我們預計將實現盈利增長的公司的免費列表。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文所引述的市場回報反映了目前在美國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?對內容感到擔憂?請直接與我們聯繫。或者,發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有反饋?對內容感到擔憂?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論